Re: Amended and Restated Transitional Services and Separation AgreementSeparation Agreement • September 2nd, 2016 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Transitional Services and Separation Agreement (the “Agreement”) confirms that you and Repligen Corporation (“Repligen” or the “Company”) have reached an amicable decision for you to first transition from your role as Senior Vice President, Research and Development to the role of Senior Advisor to the Company on September 1, 2016, and then for your employment relationship with the Company to end on Feb. 28, 2017, unless you or the Company elects to end your employment on an earlier date in accordance with this Agreement. For purposes of this Agreement, the actual last day of your employment shall be referred to as the “Separation Date.” This Agreement amends, restates and supersedes in all respects the Transitional Services and Separation Agreement between you and the Company dated April 29, 2016 (the “Former Agreement”).
